» Articles » PMID: 23365097

Auditory Analysis of Xeroderma Pigmentosum 1971-2012: Hearing Function, Sun Sensitivity and DNA Repair Predict Neurological Degeneration

Abstract

To assess the role of DNA repair in maintenance of hearing function and neurological integrity, we examined hearing status, neurological function, DNA repair complementation group and history of acute burning on minimal sun exposure in all patients with xeroderma pigmentosum, who had at least one complete audiogram, examined at the National Institutes of Health from 1971 to 2012. Seventy-nine patients, aged 1-61 years, were diagnosed with xeroderma pigmentosum (n = 77) or xeroderma pigmentosum/Cockayne syndrome (n = 2). A total of 178 audiograms were included. Clinically significant hearing loss (>20 dB) was present in 23 (29%) of 79 patients. Of the 17 patients with xeroderma pigmentosum-type neurological degeneration, 13 (76%) developed hearing loss, and all 17 were in complementation groups xeroderma pigmentosum type A or type D and reported acute burning on minimal sun exposure. Acute burning on minimal sun exposure without xeroderma pigmentosum-type neurological degeneration was present in 18% of the patients (10/55). Temporal bone histology in a patient with severe xeroderma pigmentosum-type neurological degeneration revealed marked atrophy of the cochlear sensory epithelium and neurons. The 19-year mean age of detection of clinically significant hearing loss in the patients with xeroderma pigmentosum with xeroderma pigmentosum-type neurological degeneration was 54 years younger than that predicted by international norms. The four frequency (0.5/1/2/4 kHz) pure-tone average correlated with degree of neurodegeneration (P < 0.001). In patients with xeroderma pigmentosum, aged 4-30 years, a four-frequency pure-tone average ≥10 dB hearing loss was associated with a 39-fold increased risk (P = 0.002) of having xeroderma pigmentosum-type neurological degeneration. Severity of hearing loss parallels neurological decline in patients with xeroderma pigmentosum-type neurological degeneration. Audiometric findings, complementation group, acute burning on minimal sun exposure and age were important predictors of xeroderma pigmentosum-type neurological degeneration. These results provide evidence that DNA repair is critical in maintaining neurological integrity of the auditory system.

Citing Articles

Different germline variants in the XPA gene are associated with severe, intermediate, or mild neurodegeneration in xeroderma pigmentosum patients.

Sagun J, Khan S, Imoto K, Tamura D, Oh K, DiGiovanna J PLoS Genet. 2024; 20(12):e1011265.

PMID: 39621777 PMC: 11637439. DOI: 10.1371/journal.pgen.1011265.


Physical, oral, and swallowing functions of three patients with type a xeroderma pigmentosum: a report of three cases.

Tamura A, Yamaguchi K, Yanagida R, Miyata R, Tohara H BMC Oral Health. 2024; 24(1):163.

PMID: 38302989 PMC: 10832268. DOI: 10.1186/s12903-024-03933-3.


Neurological disease in xeroderma pigmentosum: prospective cohort study of its features and progression.

Garcia-Moreno H, Langbehn D, Abiona A, Garrood I, Fleszar Z, Manes M Brain. 2023; 146(12):5044-5059.

PMID: 38040034 PMC: 10690019. DOI: 10.1093/brain/awad266.


Chemiexcitation: Mammalian Photochemistry in the Dark.

Brash D, Goncalves L Photochem Photobiol. 2023; 99(2):251-276.

PMID: 36681894 PMC: 10065968. DOI: 10.1111/php.13781.


Peripheral neuropathies associated with DNA repair disorders.

Maguina M, Kang P, Tsai A, Pacak C Muscle Nerve. 2022; 67(2):101-110.

PMID: 36190439 PMC: 10075233. DOI: 10.1002/mus.27721.


References
1.
Weidenheim K, Dickson D, Rapin I . Neuropathology of Cockayne syndrome: Evidence for impaired development, premature aging, and neurodegeneration. Mech Ageing Dev. 2009; 130(9):619-36. DOI: 10.1016/j.mad.2009.07.006. View

2.
Spoor M, Nagtegaal A, Ridwan Y, Borgesius N, van Alphen B, van der Pluijm I . Accelerated loss of hearing and vision in the DNA-repair deficient Ercc1(δ/-) mouse. Mech Ageing Dev. 2012; 133(2-3):59-67. DOI: 10.1016/j.mad.2011.12.003. View

3.
Iwasaki S, Kaga K, Yagi M, Kuroda M . Vestibular findings and brainstem pathology in two siblings with Cockayne's syndrome. ORL J Otorhinolaryngol Relat Spec. 1996; 58(6):343-6. DOI: 10.1159/000276867. View

4.
Khan S, Oh K, Emmert S, Imoto K, Tamura D, DiGiovanna J . XPC initiation codon mutation in xeroderma pigmentosum patients with and without neurological symptoms. DNA Repair (Amst). 2008; 8(1):114-25. PMC: 2684809. DOI: 10.1016/j.dnarep.2008.09.007. View

5.
Kenyon G, Booth J, Prasher D, Rudge P . Neuro-otological abnormalities in xeroderma pigmentosum with particular reference to deafness. Brain. 1985; 108 ( Pt 3):771-84. DOI: 10.1093/brain/108.3.771. View